Literature DB >> 28494187

The screening of the functional microRNA binding site SNPs in sporadic colorectal cancer genes.

Hongjuan He1, Lei Lei1, Erfei Chen1, Xiaona Xu1, Lili Wang1, Junqiang Pan1, Fangfang Yang1, Min Wang1, Jing Dong1, Jin Yang1.   

Abstract

Sporadic colorectal cancer (sCRC) is one of the most commonly diagnosed cancers worldwide, but few genetic markers have been identified and used for its early detection. MicroRNAs are diverse cellular regulators in cancer pathogenesis that bind to the 3'-untranslated region (3'-UTR) of their target mRNAs, and variants within the miRNA target sites on sCRC-related genes may influence its pathogenesis. To investigate this possibility, we used a bioinformatical method to screen SNPs for putative changes in miRNA recognition sites within the 3'-UTR of sCRC-related genes. The rs11466537 single nucleotide polymorphism was predicted to modify the regulation of hsa-miR-1193 on the Transforming Growth Factor β Receptor II (TGFBR2) gene. Additionally, luciferase reporter assays indicated that hsa-miR-1193 bound the T allele more strongly than the A allele of rs11466537 (with A being the less frequent variant), and real time-polymerase chain reaction and western blot analysis showed that TGFBR2 is significantly repressed by hsa-miR-1193. Furthermore, overexpression of hsa-miR-1193 promoted HT-29 cell proliferation, while the loss of hsa-miR-1193 inhibited the process. Finally, the rs11466537 genotyping result revealed that the frequency of A allele carriers was 1.5% in the control blood samples, but 0 in the sCRC patients' normal colon tissue samples. Our results demonstrated that hsa-miR-1193 may be involved in sCRC tumourigenesis at least in part by suppression of TGFBR2, and the A allele of rs11466537 disturbed the regulation of hsa-miR-1193 on TGFBR2.

Entities:  

Keywords:  3′-untranslated region; TGFBR2; microRNA; protective factor; seed region; single nucleotide polymorphisms; sporadic colorectal cancer

Mesh:

Substances:

Year:  2017        PMID: 28494187      PMCID: PMC5536933          DOI: 10.1080/15384047.2017.1323584

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  26 in total

1.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

2.  A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target.

Authors:  Jennifer Lee; Uwe Warnken; Martina Schnölzer; Johannes Gebert; Jürgen Kopitz
Journal:  Protein Sci       Date:  2015-07-30       Impact factor: 6.725

Review 3.  Early-onset colorectal cancer: a sporadic or inherited disease?

Authors:  Vittoria Stigliano; Lupe Sanchez-Mete; Aline Martayan; Marcello Anti
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

4.  Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.

Authors:  Swati Biswas; Patricia Trobridge; Judith Romero-Gallo; Dean Billheimer; Lois L Myeroff; James K V Willson; Sanford D Markowitz; William M Grady
Journal:  Genes Chromosomes Cancer       Date:  2008-02       Impact factor: 5.006

5.  Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway.

Authors:  Eduardo Vilar; Bhramar Mukherjee; Rork Kuick; Leon Raskin; David E Misek; Jeremy M G Taylor; Thomas J Giordano; Samir M Hanash; Eric R Fearon; Gad Rennert; Stephen B Gruber
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

Review 6.  Recent advances in colorectal cancer genetics and diagnostics.

Authors:  Peh Yean Cheah
Journal:  Crit Rev Oncol Hematol       Date:  2008-09-06       Impact factor: 6.312

7.  NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population.

Authors:  Shunxin Song; Dianke Chen; Jiachun Lu; Jiawei Liao; Yanxin Luo; Zuli Yang; Xinhui Fu; Xinjuan Fan; Yisheng Wei; Lei Yang; Lei Wang; Jianping Wang
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

Review 8.  Genetic and epigenetic traits as biomarkers in colorectal cancer.

Authors:  Marianne Berg; Kjetil Søreide
Journal:  Int J Mol Sci       Date:  2011-12-16       Impact factor: 5.923

9.  Population-specific common SNPs reflect demographic histories and highlight regions of genomic plasticity with functional relevance.

Authors:  Ananyo Choudhury; Scott Hazelhurst; Ayton Meintjes; Ovokeraye Achinike-Oduaran; Shaun Aron; Junaid Gamieldien; Mahjoubeh Jalali Sefid Dashti; Nicola Mulder; Nicki Tiffin; Michèle Ramsay
Journal:  BMC Genomics       Date:  2014-06-06       Impact factor: 3.969

Review 10.  For robust big data analyses: a collection of 150 important pro-metastatic genes.

Authors:  Yan Mei; Jun-Ping Yang; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2017-01-21
View more
  3 in total

1.  High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.

Authors:  Le Du; Jingchuan Li; Lei Lei; Hongjuan He; Erfei Chen; Jing Dong; Jin Yang
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

2.  Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based study.

Authors:  Erfei Chen; Fangfang Yang; Hongjuan He; Qiqi Li; Wei Zhang; Jinliang Xing; Ziqing Zhu; Jingjing Jiang; Hua Wang; Xiaojuan Zhao; Ruitao Liu; Lei Lei; Jing Dong; Yuchen Pei; Ying Yang; Junqiang Pan; Pan Zhang; Shuzhen Liu; Le Du; Yuan Zeng; Jin Yang
Journal:  Mol Cancer       Date:  2018-12-20       Impact factor: 27.401

3.  MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.

Authors:  Morteza Gholami; Bagher Larijani; Farshad Sharifi; Shirin Hasani-Ranjbar; Reza Taslimi; Milad Bastami; Rasha Atlasi; Mahsa M Amoli
Journal:  Cancer Med       Date:  2019-10-21       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.